604 related articles for article (PubMed ID: 16619467)
21. Recombinant DNA research: actions under the guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1995 Apr; 60(81):20726-37. PubMed ID: 11656763
[No Abstract] [Full Text] [Related]
22. Regulation of genetic modification of organisms: science or emotion?
Malinowski MJ
J Biolaw Bus; 1998; 1(3):3-7. PubMed ID: 11657280
[No Abstract] [Full Text] [Related]
23. White House to release biotechnology guidelines.
Sun M
Science; 1986 Jun; 232(4755):1189. PubMed ID: 11643922
[No Abstract] [Full Text] [Related]
24. The Cambridge model: how public oversight of biotech is good for everyone--even business.
Lipson S
Genewatch; 2003; 16(5):7-10. PubMed ID: 15025120
[No Abstract] [Full Text] [Related]
25. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
Talbot B
Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
[No Abstract] [Full Text] [Related]
26. Biotechnology: can a new technology survive?
Withers WW; Kenworthy PG
St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845
[No Abstract] [Full Text] [Related]
27. Molecular biology or molecular politics? The production of scientific consensus on the hazards of recombinant DNA technology.
Wright S
Soc Stud Sci; 1986 Nov; 16(4):593-620. PubMed ID: 11650809
[No Abstract] [Full Text] [Related]
28. Regulating the environmental release of genetically engineered organisms: Foundation on Economic Trends v. Heckler.
Pendorf S
Fla State Univ Law Rev; 1985; 12(4):891-921. PubMed ID: 11653640
[No Abstract] [Full Text] [Related]
29. Proposal for a coordinated framework for regulation of biotechnology.
U.S. Office of Science and Technology Policy
Fed Regist; 1984 Dec; 49(252):50856-907. PubMed ID: 11655658
[No Abstract] [Full Text] [Related]
30. Recombinant DNA Advisory Committee: minutes of meeting, 14 Jan 1993.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1993 Aug; 4(4):529-44. PubMed ID: 11643161
[No Abstract] [Full Text] [Related]
31. Regulating human gene therapy.
Areen J
West VA Law Rev; 1985; 88(2):153-71. PubMed ID: 11655150
[No Abstract] [Full Text] [Related]
32. Recombinant DNA research; actions under guidelines; notice.
U.S. National Institutes of Health
Fed Regist; 1985 Mar; 50(47):9760-7. PubMed ID: 11655783
[No Abstract] [Full Text] [Related]
33. Biotechnology and culture: the impact of public debates on government regulation in the United States and Denmark.
Baark E; Jamison A
Technol Soc; 1990; 12(1):27-44. PubMed ID: 11650912
[No Abstract] [Full Text] [Related]
34. Gene-splice approvals on two fronts.
Miller JA
Sci News; 1985 Nov; 128(21):324. PubMed ID: 11653676
[No Abstract] [Full Text] [Related]
35. Recombinant DNA research; actions under guidelines; notice of actions.
U.S. National Institutes of Health
Fed Regist; 1986 May; 51(88):16952-6. PubMed ID: 11655846
[No Abstract] [Full Text] [Related]
36. Regulatory structure for biotechnology proposed.
Sun M
Science; 1985 Jan; 227(4684):274. PubMed ID: 11643694
[TBL] [Abstract][Full Text] [Related]
37. Biotechnology: new plans for regulation.
Beardsley T
Nature; 1985 Oct; 317(6036):373. PubMed ID: 11653653
[No Abstract] [Full Text] [Related]
38. State biotechnology oversight: the juncture of technology, law, and public policy.
Vito CC
Maine Law Rev; 1993; 45(2):329-83. PubMed ID: 11652701
[No Abstract] [Full Text] [Related]
39. Panel that reviews gene tests in humans has no applications.
Weiss R
Washington Post; 1996 Feb; ():A3. PubMed ID: 11647100
[No Abstract] [Full Text] [Related]
40. Genetic engineering and related biotechnologies: scientific progress and public policy.
Perpich JG
Technol Soc; 1983; 5(1):27-49. PubMed ID: 11650684
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
